Katsunori Jinnouchi

Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes

Seigo Sugiyama, Hideaki Jinnouchi, Noboru Kurinami et al. · Journal of Atherosclerosis and Thrombosis · 2017 · 103 citations · Full text

The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus

Seigo Sugiyama, Hideaki Jinnouchi, Noboru Kurinami et al. · Internal Medicine · 2018 · 76 citations · Full text

Pancreatic Sphincter Precutting to Gain Selective Access to the Common Bile Duct: A Series of 172 Patients

Ryukiti AKASHI, Takeaki Kiyozumi, Katsunori Jinnouchi et al. · Endoscopy · 2004 · 59 citations

Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus

Noboru Kurinami, Seigo Sugiyama, Hiroyuki Nishimura et al. · Clinical Drug Investigation · 2017 · 26 citations · Full text

Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center

Seigo Sugiyama, Hideaki Jinnouchi, Akira Yoshida et al. · Journal of Clinical Medicine Research · 2019 · 26 citations · Full text